Gilgamesh Pharmaceuticals

Overview

Gilgamesh Pharma develops novel small molecules for psychiatric diseases, using medicinal chemistry and an AI-powered translational platform to target relevant brain mechanisms and restore function.

Part of the New York ecosystem

Related

• Andreessen HorowitzInvests in seed through growth-stage technology companies and operates a venture support platform for founders needing help across company-building functions and stages.
• Columbia UniversityMajor research university in New York with strong AI, biotech, and applied science programs. Anchor of Manhattan's tech research ecosystem.
• EvolutionaryScaleBuilds AI models for biology and protein design, offering ESM3 tools and open resources for scientists studying proteins and health-related biology.
• General CatalystInvests in portfolio companies and acquired a hospital system to test a model for more proactive, accessible, affordable healthcare for American patients.
• GiantLeap CapitalInvests in technology companies in private and public markets, pursuing tactical and special-situation opportunities and working with management teams through growth or transition.
• HexemBioBuilds rejuvenated stem cell therapy aimed at improving aged hematopoietic stem cells and bone marrow transplant outcomes for blood cancer patients.
• HOF CapitalVenture investor partnering with mission-driven technology builders, helping founders tackle difficult technical problems and scale infrastructure and applications through industry leader networks.
• Lux CapitalInvests in emerging science and technology companies and publishes scenarios, analyses, podcasts, and newsletters for audiences tracking strategic challenges and future developments.
• Precision NeuroscienceDevelops an investigational brain-computer interface intended to let people with paralysis control digital devices through thought, working with clinical partners on research.
• Renaissance PhilanthropyBuilds time-bound, thesis-driven philanthropic funds and playbooks that help philanthropists and foundations support science, technology, and innovation ideas without large expert teams.
• Schrödinger ($SDGR)Develops a physics-based computational platform to discover, optimize, and formulate molecules and materials for drug discovery teams and materials science researchers.
• SynchronBuilds implantable brain-computer interfaces delivered through blood vessels, with a device in clinical trials for people living with paralysis to support communication and independence.